Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) Transcript
Hi, everybody, and thank you for joining us today. Our last discussion for today is with the Gilead team. We've got Merdad and Johanna here to talk to us, representing the R&D and commercial sides of Gilead. So thank you both for making the time for us today. I really, really appreciate it.
As Gilead is kind of a company with like an HIV -- largely HIV-based and an oncology product on top of it, we thought about dividing the discussion to just that. We'll first talk a little bit of oncology, which has a few of the near-term catalysts, and then go over to HIV and discuss both the R&D and commercial sides there.
Questions & Answers
So Merdad, we'll start with you. You came to Gilead from Roche. And in your -- and you've got a long career in the industry. What is your take, what does Gilead have that is special on the R&D side? What do they have that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
